MET and non-small cell lung carcinoma: Aberrant HGF/MET signaling is associated with a poorer overall survival in NSCLC patients [157,201,202,203] and contributes to tumorigenesis by facilitating anchorage independent growth of NSCLC cells in a STAT3-dependent manner [204].